Ryan Crowe | VP, IR |
Dave Marek | CEO |
Lauren Merendino | CCO |
Frank Karbe | President and CFO |
Juan Camilo Arjona Ferreira | Chief Medical Officer |
Jason Butler | JMP Securities |
Eric Joseph | J.P. Morgan |
Phil Nadeau | Cowen & Company |
Brian Skorney | Baird |
Unidentified Analyst | Evercore ISI |
Paul Choi | Goldman Sachs |
Good day everyone and welcome to Myovant Sciences First Quarter of Fiscal Year 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, Vice President of Investor Relations at Myovant. Please go ahead.
Thank you, operator.